ArticlePloS one2022

Evaluation of the clinical utility of the PromarkerD in-vitro test in predicting diabetic kidney disease and rapid renal decline through a conjoint analysis.

Lauren Fusfeld et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.